A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret prostate-specific antigen (PSA) test results compared to existing models.

Retinoic acid suppresses immune defenses against cancer, but a new drug KyA33 boosts vaccine success and slows tumor growth ...

Increased use of organoids in cancer research: The Würzburg lighthouse project "Preclinical Models" is working towards this ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

NAYA's European Hub to Accelerate Clinical Development of its Astatine-211 Targeted Alpha Therapies and Multispecific ...

A higher intake of food preservatives, widely used in industrially processed foods and beverages to extend shelf-life, is ...

Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.

A study that was published in recent weeks has given the world a sobering view of the number of cancer diagnoses that are ...

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) announced today that its 2026 funding opportunities are officially open for applications.

A new white paper from BioDlink, From Complexity to Consistency: How CDMOs Can Unlock One-Step, High-Yield and Homogeneous ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its ...